Urologi Sandfeldt AB

Active
559163-2145Limited company (AB)Registered 2018TULLINGE

Key figures

0 kr
Revenue 2024/25
0500 k1 m1,5 m2 m2018/192019/202020/212021/222022/232023/242024/25

Key figures

2024/25

Summary: Urologi Sandfeldt AB

What kind of company is it?

Urologi Sandfeldt AB (org. no. 559163-2145) is a limited company (AB). The company was registered in 2018 and has existed for 8 years. Registered seat: Tullinge. Industry according to Statistics Sweden: specialist medical practice activities, not at hospitals (SNI 86222).

How is the company doing financially?

The company had no net sales in financial year 2025. Financial year 2025 ended with a loss of 390 kr. The company was profitable in 2 of the 7 reported financial years. According to the annual report, the company had no employees in financial year 2025. At the end of financial year 2025, total assets were 51 088 kr and equity 51 088 kr (equity ratio 100 %).

Where does the data come from and how up to date is it?

Company details and digitally filed annual reports come from the open data of the Swedish Companies Registration Office (Bolagsverket) and the industry code from Statistics Sweden (CC BY 2.5 SE); bolagsprofil.se updates them daily. The latest annual report is signed by one person. Data as of 2026-11-16. Changes, averages and ratios are calculated by bolagsprofil.se from open data and are not an official assessment.

Dividend

from the annual report
2022/23

Proposed dividend 30 000 kr.

History
2022/2330 000 kr
2021/22187 550 kr
2020/21183 700 kr
2019/20177 100 kr
Summary of annual reports2019–2025
2020/212021/222022/232023/242024/25
Sales revenue646 6951000
Profit for the reporting year50 021−6 590−10 591−4 502−390
Retained earnings of previous periods—————
Total assets400 473294 12190 48053 91651 088
Total liabilities−73 93710 0004 5002 4380
Total equity474 410284 12185 98051 47851 088
Employees10000
Proposed dividend183 700187 55030 000——

A dash (—) means the report has not been filed or the line is not reported; 0 is a zero stated in the report.